Kclavis

R&R Lab is a semiconductor manufacturing startup that develops heat treatment equipment.

Nuon Media is an Internet e-book store that sells famous domestic romance martial arts fantasy fantasy novels.

Inkle is a facility data platform that offers industrial software technology services for equipment makers and producers.

HandHug is a content commercialization company that operates an e-commerce platform designed to facilitate the creation and sale of products and brands in collaboration with creators. The company provides the necessary infrastructure for developing new products, enabling creators to build their brands effectively and market their offerings. By focusing on the intersection of content and commerce, HandHug aims to empower creators to monetize their work while offering consumers access to innovative products.

Selecxine is a biopharmaceutical development company focused on creating innovative immunotherapeutics for cancer treatment. The company specializes in the development of anti-cancer drugs that enhance the immune response by regulating cytokine functions, which are crucial for activating immune cells. Through its advanced platform technology, Selecxine employs a unique antibody development process to discover and develop these therapeutics. The goal is to provide safe and effective treatment options that improve both the survival rates and quality of life for cancer patients.

Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.

StradVision, Inc. specializes in developing advanced perception algorithms designed to enhance the capabilities of vehicles in recognizing and understanding their surroundings. Founded in 2014 and headquartered in Seoul, South Korea, with additional offices in California, Japan, India, China, and Germany, the company provides solutions such as SVNet External for external vehicle perception and SVNet Internal for monitoring driver and passenger status. StradVision's technology supports advanced driver assistance systems and autonomous vehicle applications, utilizing camera-based perception AI and LiDAR to ensure safety and accuracy in real-time object detection and classification. The company has achieved notable rankings in technology evaluations and holds over 60 issued patents, with more than 150 pending, reflecting its commitment to innovation in the automotive sector. Its auto labeling tool enhances data training efficiency, minimizing the need for human intervention and facilitating the development of reliable self-driving capabilities.

BeyondBio is a biotechnology company focused on the research and development of synthetic pharmaceutical drugs. The firm aims to create therapeutic drugs that address life-threatening diseases for which effective treatments are currently unavailable, including pancreatic cancer, Alzheimer's disease, and glioblastoma. By developing innovative drug candidates and therapies, BeyondBio seeks to enhance the ability of medical practitioners to protect individuals from these serious health conditions.

Panolos Bioscience is a biotechnology firm focused on developing biological drugs specifically for cancer therapy. The company has created a multi-specific drug creation platform that utilizes anti-angiogenesis-based artifact re-targeting tri-specifics, commonly referred to as ART. This innovative approach aims to reduce the side effects associated with traditional single-target protein therapeutics. By employing a multi-targeting strategy, Panolos Bioscience not only enhances the efficacy of cancer treatment but also facilitates the expansion of new drug pipelines, ultimately providing patients with access to novel therapies for cancer.

Lemonex Inc. is a biotechnology company based in Seoul, South Korea, founded in 2013. It specializes in the development and commercialization of biotherapeutics aimed at treating cancers and other challenging diseases. The company focuses on cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex offers innovative drug delivery solutions, including DegradaBALL, which facilitates the delivery of drug candidates into cultured cells and lesions, and PANGO, a technology for the rapid screening of antiviral drugs. Additionally, Lemonex is engaged in advancing biosensor technology, enhancing the effectiveness of drug delivery methods for healthcare professionals.

Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.

TESSA operates as an alternative investment platform that facilitates the purchase, sale, and trade of fractional ownership interests in investment-grade blue-chip artwork, including works by renowned artists such as Warhol, Picasso, and Basquiat. By tokenizing these artworks, TESSA provides users with the opportunity to co-own pieces represented digitally on a public blockchain, enhancing accessibility and liquidity akin to public markets. The platform caters to “micro-collectors” and manages all aspects related to the artwork, including maintenance and administration, to maximize value and visibility. TESSA ensures transparent management of ownership certificates and transaction histories through a secure blockchain network, utilizing third-party service providers to enhance safety and reliability in the trading process.

Bertis Inc. is a proteomics-based molecular diagnostics company focused on developing and commercializing cancer-related biomarkers for early disease detection. Founded in 2014 and based in Seongnam, South Korea, the company offers Mastocheck, a screening method for diagnosing stage 1 breast cancer. Bertis is engaged in extensive research for biomarker development aimed at the early diagnosis of various carcinomas, as well as the creation of new therapeutic markers and co-markers. Utilizing advanced bio-big data analysis technologies, the company seeks to uncover biomarkers across multiple fields by integrating proteomics, genomics, and bioinformatics. Additionally, Bertis is developing an AI-based diagnostic platform to enhance the diagnosis of cancer and cardiac diseases, thereby enabling more effective early detection and treatment options for medical practitioners.

Parameta is a technology company specializing in blockchain solutions, offering comprehensive technical support to prominent global blockchain projects. Founded in 2016 and based in Seoul, South Korea, Parameta focuses on enhancing the scalability and security of existing blockchain platforms. The company utilizes innovative technologies, including SCORE Smart Contract, LFT Algorithm, Tiered System, Multi-Channel, and Modular Architecture, to maximize the utility of blockchain applications across various industries. By creating optimized environments for blockchain implementation, Parameta aims to facilitate efficient operations and drive the adoption of distributed ledger technology.

Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.

Kasa Korea Co., Ltd. is a company based in Seoul, South Korea, that specializes in developing a digital securities blockchain platform tailored for the real estate market. Established in 2018, Kasa's platform enables users to buy and trade securitized commercial real estate assets as asset-backed securities. By leveraging blockchain technology, the company aims to provide retail investors with a transparent and streamlined process for investing in real estate, facilitating the buying and selling of securitized assets in a more efficient manner.

MDimune Inc. is a therapeutics company based in Seoul, South Korea, established in 2015. It specializes in developing innovative drug delivery systems, particularly utilizing vesicles derived from immune and stem cells. The company focuses on creating targeted delivery methods to enhance the efficacy of treatments for conditions such as cancer, osteoarthritis, chronic obstructive pulmonary disease, and neurodegenerative diseases. MDimune's BioDrone platform enables the manufacture and supply of these vesicles, allowing biotechnology and pharmaceutical firms to develop novel therapeutics aimed at delivering drugs precisely to target tissues. This approach facilitates the provision of advanced anticancer therapies to patients, aligning with the company's mission to improve treatment outcomes through smart drug delivery solutions.

Datable Inc. is a company that specializes in developing digital marketing tools and services focused on data analysis. Founded in 2016 and headquartered in Seoul, South Korea, Datable creates mobile applications specifically tailored for influencer marketing. The company's solutions aim to enhance the effectiveness of marketing campaigns by leveraging data-driven insights.

Doc Talk is a messenger platform that connects patients and doctors.

A Social casino game developer.